Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.649, 2012-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
PEG IFN- -2a beats conventional therapy in hep C
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 450, 2004-01 ,pp. :
Access to resources
Recommend
Skip ibutilide therapy, proceed straight to DC cardioversion
Inpharma, Vol. 1, Iss. 1231, 2000-01 ,pp. :
Triple therapy including histamine dihydrochloride shows efficacy in chronic hepatitis C
Inpharma, Vol. 1, Iss. 1263, 2000-01 ,pp. :
Hep A vaccination not cost effective for patients with chronic hep C
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. :
Entecavir outlasts the alernatives for affordable hep B therapy
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 559, 2008-01 ,pp. :